Wegovy works systemically by entering the bloodstream and affecting appetite receptors in the brain
A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes
Gelhorn HL, Poon J-L, Davies EW, Paczkowski R, Curtis SE, Boye KS
The 4.8-star Trustpilot rating across 4,147+ reviews is the strongest on our list by a comfortable margin
These drugs stimulate insulin release, suppress glucagon, slow gastric emptying, and reduce appetitemaking them effective for both glucose control and weight management
[3] [4] Oral semaglutide tablets (Rybelsus) should be stored in their original blister packaging at room temperature, protected from moisture